Allergan Inc. said Monday that the U.S. Food and Drug Administration had approved its Ozurdex eye treatment, while reporting positive midstage results for other drugs in its pipeline.
via WSJ.com: US Business http://ift.tt/1mApATG
via WSJ.com: US Business http://ift.tt/1mApATG
Nessun commento:
Posta un commento